Mini Meeting Tolmar - BBCS 2024

May 16 - 18, 2024 Brasilia - Brazil

Mini Meeting Tolmar

12 pm – 2 pm

MINI MEETING TOLMAR

GUESTS ONLY

12 pm – 1 pm

Lunch

1 pm – 2 pm

OVELIA – A Global Phase 3 Trial of Ovarian Functional Suppression utilizing a novel 3-month formulation of leuprolide acetate

Ryan Turncliff (EUA)

Tolmar – Company Overivew
GnRH therapies and use in pre-menopausal patients
SOFT/TEXT: Considering study results in the context of patient care
Overview of the OVELIA clinical trial
Q&A